The following video is part of our "Motley Fool Conversations" series, in which consumer-goods editor and analyst Austin Smith and industrials editor/analyst Brendan Byrnes discuss topics around the investing world.

In today's edition, Austin runs the numbers on two strikingly similar consumer-goods players: Colgate (NYSE: CL) and Clorox (NYSE: CLX). On paper the two appear very similar, but there are fundamental, though subtle, differences between the two that leads Austin to like one over the other. See whether Carl Icahn was barking up the right tree when he was hunting Clorox.

Austin Smith and Brendan Byrnes have no positions in the stocks mentioned above. The Motley Fool owns shares of Clorox and Johnson & Johnson. Motley Fool newsletter services recommend Johnson & Johnson and Procter & Gamble. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.